Bridgefront Capital’s Compugen CGEN Stock Holding History

Bridgefront Capital’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,151	Closed	-$61K	–	318
2021 Q3	$61K	Buy	+10,151	New	+$68K	0.06%	290

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Bridgefront Capital's CGEN Position: Q4 2021 in Review

Bridgefront Capital sold out of Compugen (CGEN) in Q4 2021, closing a stake of 10,151 shares — an estimated $61K sold.

Bridgefront Capital first reported a position in CGEN in Q3 2021 and held it in 1 quarter. The position peaked at $61K in Q3 2021. 114 funds tracked by Wall St. Rank hold CGEN as of Q4 2021.

Bridgefront Capital reported no remaining Compugen position as of Q4 2021 after selling out during the quarter.
Bridgefront Capital sold 10,151 Compugen shares in Q4 2021, an estimated $61K.
Bridgefront Capital first reported a position in Compugen in Q3 2021 and held it in 1 quarter.
Bridgefront Capital's Compugen position peaked at $61K in Q3 2021.
114 funds tracked by Wall St. Rank held Compugen as of Q4 2021.

Based on Bridgefront Capital's 13F filing for Q4 2021, filed 10 Feb 2022.